Gene-modified T-cell therapy (CAR-T)

· CARsgen Therapeutics Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Gene-modified T-cell therapy (CAR-T), covering 2025-02-13 to 2025-02-13. Get the full timeline:

Most recent: Clinical Trial Update: Long Term Follow-up Observational Study in Patients Treated with Gene-Modified T-Cell Therapy